• Ownership

Mark Chin - Insider Trading & Ownership

Entity
Individual
Location
20 Berkeley Square, Mayfair, London, United Kingdom
Summary
The estimated net worth of Mark Chin is at least $35.7M dollars as of June 14, 2024. Mark Chin is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $35.5M. Mark Chin is the Former Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $162K. Mark Chin is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $32.2K. Mark Chin is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $25.6K.
All Insider Reports
All Insider Reports

Ownership of Mark Chin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN, IMRA Enliven Therapeutics, Inc. Director $35.5M Jun 2, 2022
PYXS Pyxis Oncology, Inc. Former Director $162K Apr 21, 2022
HARP Harpoon Therapeutics, Inc. Director $32.2K Mar 8, 2024
ITRM Iterum Therapeutics plc Director $25.6K Jun 15, 2023
IRON Disc Medicine, Inc. Director Jun 12, 2024

Insider Transactions Reported by Mark Chin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.